<DOC>
	<DOCNO>NCT02499315</DOCNO>
	<brief_summary>The purpose study find AMG 357 safe tolerate woman Rhematoid Arthritis .</brief_summary>
	<brief_title>Study Evaluate Safety , Tolerability , Action AMG 357 Females With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Subject provide informed consent . Rheumatoid arthritis present ≥ 3 month . Global functional class I , II , III . History positive , Rheumatoid Arthritis Taking methotrexate consecutively ≥ 12 week stable dose 1025 mg weekly . Subjects currently take NSAIDs oral corticosteroid . Normal ECG value Immunizations date . Positive Hepatitis B , Hepatitis C , Positive HIV Sensitivity product component administer . Malignancy within 3 year Presence recurrent chronic infection Evidence infection within 30 day prior randomization Presence serious infection Prosthetic joint infection within 3 year native joint infection within 1 year History exposure tuberculosis without history prophylactic treatment Class IV RA . Felty 's syndrome Chronic pelvic pain hemorrhagic ovarian cyst within 3 year Any bleed disorder clinically significant Low white blood cell neutrophil count Elevated serum creatinine clearance Low hemoglobin platelet count Received live vaccine within 3 month first dose Alcohol and/or substance abuse within past 12 month Blood donation within 60 day Positive urine screen drug abuse Any prior use rituximab last 6 month ( B cell deplete agent ) CD19 level &lt; low limit normal Use weekly bimonthly biologic within 2 week monthly biologic agent within 4 week Corticosteroid injection acute RA flare within 4 week Grapefruit juice grapefruit containing product within 7 day first dose . All herbal medicine , vitamin , supplement within 30 day The use experimental/investigational biologic DMARD unless agent 3 month ; 6 month B cell deplete agent Known GI disease GI procedures Women reproductive potential unwilling practice birth control Women pregnant/lactating/breastfeeding Subject IgG level &lt; low limit normal screening</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>